Skip to content

Medicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy
Source link
Tags: 4523.TO, Alzheimer's Disease, BIIB, Biogen, Biotechnology, C&E Industry News Filter, Content Types, corporate, Corporate/Industrial News, Dementia, development, Domestic Politics, Eisai, Factiva Filters, Financial Services, general news, government policy, Government Sponsored Health Insurance, Health, Health/Medical Insurance, healthcare, Healthcare/Life Sciences, industrial news, Insurance, international relations, JP:4523, life sciences, Medical Conditions, medical insurance, medications, Mental Disorders, Neurodegenerative Disease Drugs, new product, New Product/Service Testing, new products, New Products/Services, Non-life Insurance, Pharmaceuticals, political, Political/General News, politics, Politics/International Relations, product, Product/Service Approvals, products, Products/Services, regulation, Regulation/Government Policy, research, Research/Development, service approvals, service testing, services, specialized drugs, Specialized Drugs/Medications, SYND, WSJ-PRO-WSJ.com, wsjhealth